gliclazide has been researched along with Acute Kidney Failure in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, C | 1 |
| Ma, P | 1 |
| Zhao, Z | 1 |
| Jiang, N | 1 |
| Lian, D | 1 |
| Huo, P | 1 |
| Yang, H | 1 |
1 other study available for gliclazide and Acute Kidney Failure
| Article | Year |
|---|---|
miRNA‑mRNA regulatory network analysis of mesenchymal stem cell treatment in cisplatin‑induced acute kidney injury identifies roles for miR‑210/Serpine1 and miR‑378/Fos in regulating inflammation.
Topics: Acute Kidney Injury; Animals; Cisplatin; Computational Biology; Databases, Genetic; Datasets as Topi | 2019 |